PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2024 to 2028

The pandemic drove PCR into a dominant technology role but now new markets and technologies are opening up that will change how diseases are diagnosed. PCR plays a central role. Find out about the opportunities and threats in this new global market.

The report forecasts the market size out five years with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance The two key trends of Point of Care Testing and Molecular Diagnostics are merging but what does that look like? Find out in this comprehensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research Seminar - Burke Institute
Finance for Senior Executives - Harvard Business School

1. Market Guides

1.1. Situation Analysis
1.2. Guide for Executives and Marketing Staff
1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

2.1. What are PCR Technologies?
2.2. PCR and Syndromic Testing
2.3. Market Definition
- 2.3.1. Market Size
- 2.3.2. Currency
- 2.3.3. Years
2.4. Methodology
- 2.4.1. Methodology
- 2.4.2. Sources
- 2.4.3. Authors
2.5. Perspective: Healthcare and the IVD Industry
- 2.5.1. Global Healthcare Spending
- 2.5.2. Spending on Diagnostics
- 2.5.3. Important Role of Insurance for Diagnostics

3. PCR-Guide to PCR Technologies

3.1. Concepts
- 3.1.1. Method
3.2. Applications
- 3.2.1. Finding Specific DNA
- 3.2.2. Measuring DNA
- 3.2.3. Medical and Diagnostic Applications
  - 3.2.3.1. Carrier, prenatal and tissue typing
  - 3.2.3.2. Cancer Diagnosis and Management
  - 3.2.3.3. Infectious Disease-New Levels of Accuracy and Sensitivity
  - 3.2.3.4. Forensic Applications
  - 3.2.3.5. Science and Research
3.3. PCR-Advantages and Disadvantages
3.4. Different Types of PCR
- 3.4.1. Simple Changes
  - 3.4.1.1. Multiplex-PCR
  - 3.4.1.2. VNTR PCR
  - 3.4.1.3. Asymmetric PCR
  - 3.4.1.4. Long PCR
  - 3.4.1.5. Nested PCR
  - 3.4.1.6. Quantitative PCR
  - 3.4.1.7. Hot-start PCR
  - 3.4.1.8. Touchdown PCR
  - 3.4.1.9. Assembly PCR
  - 3.4.1.10. Colony PCR
  - 3.4.1.11. Suicide PCR
  - 3.4.1.12. Cold PCR
- 3.4.2. Digital PCR
  - 3.4.2.1. Droplet Digital PCR
  - 3.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
  - 3.4.2.3. Digital PCR in Use
  - 3.4.2.4. Digital PCR Commercial History
- 3.4.3. Isothermal PCR

4. Industry Overview

4.1. Players in a Dynamic Market
- 4.1.1. Academic Research Lab
- 4.1.2. Diagnostic Test Developer
- 4.1.3. Instrumentation Supplier
- 4.1.4. Chemical/Reagent Supplier
- 4.1.5. Pathology Supplier
- 4.1.6. Independent Clinical Laboratory
- 4.1.7. Public National/regional Laboratory
- 4.1.8. Hospital Laboratory
- 4.1.9. Physicians Office Lab (POLS)
- 4.1.10. Audit Body
- 4.1.11. Certification Body

5. Market Trends

5.1. Factors Driving Growth
- 5.1.1. A New Standard
- 5.1.2. Down the Curve We Go
- 5.1.3. Multiplexing
- 5.1.4. Syndromic Diagnostics Looks Unstoppable
- 5.1.5. The Genetic Blizzard
5.2. Factors Limiting Growth
- 5.2.1. The Cost Curve
- 5.2.2. The Other Guys
- 5.2.3. Systemic Roadblocks
5.3. Diagnostic Technology Development
- 5.3.1. The Instrumentation Curve
- 5.3.2. Shifting Role of Diagnostics
- 5.3.3. Diagnostics Moves Out of the Hospital
- 5.3.4. Disruption Looms
- 5.3.5. The Next Five Years

6. PCR Recent Developments

6.1. Recent Developments-Importance and How to Use This Section
- 6.1.1. Importance of These Developments
- 6.1.2. How to Use This Section
6.2. Seegene, Microsoft Collaborate for MDx Development
6.3. QuidelOrtho Expanding Savanna Test Menu
6.4. Binx Health Refocuses on POC STI Testing
6.5. Qiagen, Myriad Genetics Partner to Develop Cancer Dx
6.6. VedaBio Detecting Nucleic Acid With CRISPR
6.7. Evvy Launches Add-on STI Screen
6.8. ChromaCode Shifts to Oncology with dPCR Lung Cancer Test
6.9. Multiplex Meningitis/Encephalitis Panel Market Expanding
6.10. Sensible Dx to Launch 10-Minute POC PCR System
6.11. ReadyGo Dx Plans to Make MDx Testing Easy
6.12. Transformative Biotech Acquires Summit Biolabs' PCR Tech
6.13. Visby Medical POC STI Multiplex Test Cleared
6.14. Sherlock Biosciences Buys Sense Biodetection
6.15. Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx
6.16. HealthTrackRx Investing in Rapid Turnaround Times
6.17. LEX Dx Developing Ultra-Fast Low-Cost PCR
6.18. Next-Gen Dx Technologies Face Uncertain Future
6.19. Rover Dx Developing All-Optical Rapid POC qPCR Platform
6.20. ProtonDx Plans Rapid Molecular Dx Instrument
6.21. Innova Medical Group Licenses MDx Tech
6.22. MicroGEM to Grow Market for 30-Minute RT-PCR System
6.23. Precipio Receives CE-IVD Mark for Cancer Panels
6.24. Siemens Healthineers to Develop Next-Gen MDx Platform
6.25. New York State Approves Enzo Biochem HPV Molecular Test
6.26. Grip Molecular Developing Biosensor Panel to Detect Respiratory Infections
6.27. Co-Diagnostics Seeks EUA for At-Home PCR Diagnostic System
6.28. Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
6.29. Finnish Firms to Form Point-of-Care Testing Firm
6.30. Visby Medical Scales Up Handheld PCR Test for STIs
6.31. DnaNudge Raises $60M
6.32. Roche Reports Diagnostics Revenue Up 51 Percent
6.33. BforCure Preparing Multiple ID Panels for PoC qPCR Platform
6.34. Enzo Biochem, CLX Health Partner for C19 Testing for Travel
6.35. Bio Molecular Systems Gets Approval for Portable PCR Cycler
6.36. Roche Acquires GenMark
6.37. Handheld qPCR Devices Close to Commercialization
6.38. Nuclein Closes $14M in Funding
6.39. WuXi Diagnostics Closes $150M Series B Financing Round
6.40. Visby Medical to develop rapid Flu-COVID PCR test
6.41. Thermo Fisher to acquire Mesa Biotech

7. Profiles of Key PCR Companies

7.1. Abbott Laboratories
7.2. Accelerate Diagnostics
7.3. Ador Diagnostics
7.4. ADT Biotech
7.5. Agilent
7.6. Akonni Biosystems
7.7. Altona Diagnostics
7.8. Alveo Technologies
7.9. Amoy Diagnostics Co., Ltd.
7.10. Anatolia Geneworks
7.11. Applied BioCode
7.12. Applied DNA Sciences
7.13. Aurora Biomed
7.14. Aus Diagnostics
7.15. AVIVA Systems Biology
7.16. Beckman Coulter Diagnostics (Danaher)
7.17. Becton, Dickinson and Company
7.18. Binx Health
7.19. Biocartis
7.20. bioMerieux Diagnostics
7.21. Bioneer Corporation
7.22. Bio-Rad Laboratories, Inc
7.23. Bosch Healthcare Solutions GmbH
7.24. Bruker
7.25. Caris Molecular Diagnostics
7.26. Cepheid (Danaher)
7.27. Credo Diagnostics Biomedical
7.28. CTK Biotech
7.29. Cue Health
7.30. Curetis (OpGen)
7.31. Diagenode Diagnostics (Hologic)
7.32. Diasorin S.p.A.
7.33. Eiken Chemical
7.34. Enzo Biochem
7.35. Eurofins Scientific
7.36. Fluxergy
7.37. Fujirebio
7.38. Genetic Signatures
7.39. GenMark Dx (Roche)
7.40. Greiner Bio-One
7.41. Hologic
7.42. Immunexpress
7.43. Inflammatix
7.44. Invetech
7.45. J&J Innovative Medicine
7.46. Karius
7.47. LumiraDx
7.48. Maxim Biomedical
7.49. Meridian Bioscience
7.50. Millipore Sigma
7.51. Molbio Diagnostics
7.52. Nanomix
7.53. NGeneBio
7.54. Novacyt
7.55. Nuclein
7.56. Operon
7.57. Panagene
7.58. Precipio
7.59. Primerdesign (Novacyt)
7.60. Promega
7.61. Prominex
7.62. Qiagen
7.63. QuantuMDx
7.64. QuidelOrtho
7.65. Randox Toxicology
7.66. R-Biopharm AG
7.67. Revvity
7.68. Roche Diagnostics
7.69. Scope Fluidics
7.70. SD Biosensor
7.71. Seegene
7.72. Siemens Healthineers
7.73. SkylineDx
7.74. Sona Nanotech
7.75. SpeeDx
7.76. Standard BioTools
7.77. Stilla Technologies
7.78. Streamline Scientific
7.79. T2 Biosystems
7.80. Thermo Fisher Scientific
7.81. Uniogen
7.82. Vela Diagnostics
7.83. Veramarx
7.84. Veredus Laboratories
7.85. Vircell
7.86. Visby Medical
7.87. XCR Diagnostics
7.88. YD Diagnostics
7.89. Zhejiang Orient Gene Biotech

8. The Global PCR Markets

8.1. PCR-Global Market Overview by Country
- 8.1.1. Table-Global Market by Country
- 8.1.2. Chart-Global Market by Country
8.2. Global Market by Application-Overview
- 8.2.1. Table-Global Market by Application
- 8.2.2. Chart-Global Market by Application-Segments Growth
- 8.2.3. Chart-Global Market by Application-Base/Final Comparison
- 8.2.4. Chart-Global Market by Application-Base Year
- 8.2.5. Chart-Global Market by Application-Final Year
- 8.2.6. Chart-Global Market by Application-Share by Year
8.3. Global Market by Technology-Overview
- 8.3.1. Table-Global Market by Technology
- 8.3.2. Chart-Global Market by Technology-Segments Growth
- 8.3.3. Chart-Global Market by Technology-Base/Final Comparison
- 8.3.4. Chart-Global Market by Technology-Base Year
- 8.3.5. Chart-Global Market by Technology-Final Year
- 8.3.6. Chart-Global Market by Technology-Share by Year
8.4. Global Market by Product-Overview
- 8.4.1. Table-Global Market by Product
- 8.4.2. Chart-Global Market by Product-Segments Growth
- 8.4.3. Chart-Global Market by Product-Base/Final Comparison
- 8.4.4. Chart-Global Market by Product-Base Year
- 8.4.5. Chart-Global Market by Product-Final Year
- 8.4.6. Chart-Global Market by Product-Share by Year
8.5. Global Market by Place-Overview
- 8.5.1. Table-Global Market by Place
- 8.5.2. Chart-Global Market by Place-Segments Growth
- 8.5.3. Chart-Global Market by Place-Base/Final Comparison
- 8.5.4. Chart-Global Market by Place-Base Year
- 8.5.5. Chart-Global Market by Place-Final Year
- 8.5.6. Chart-Global Market by Place-Share by Year

9. Global PCR Markets-By Application

9.1. PCR Clinical Multiplex
- 9.1.1. Table PCR Clinical Multiplex Testing-by Country
- 9.1.2. Chart-PCR Clinical Multiplex Testing Growth
9.2. PCR Clinical Singleplex
- 9.2.1. Table PCR Clinical Singleplex Testing-by Country
- 9.2.2. Chart-PCR Clinical Singleplex Testing Growth
9.3. PCR Research
- 9.3.1. Table PCR Research-by Country
- 9.3.2. Chart-PCR Research Growth
9.4. PCR Other Application
- 9.4.1. Table PCR Other Application-by Country
- 9.4.2. Chart-Other Application Growth

10. Global PCR Markets-By Technology

10.1. qPCR
- 10.1.1. Table qPCR-by Country
- 10.1.2. Chart-qPCR Growth
10.2. dPCR
- 10.2.1. Table dPCR-by Country
- 10.2.2. Chart-dPCR Growth
10.3. Other Technology
- 10.3.1. Table Other Technology-by Country
- 10.3.2. Chart-Other Technology Growth

11. Global PCR Markets-By Product

11.1. PCR Instruments
- 11.1.1. Table PCR Instruments-by Country
- 11.1.2. Chart-PCR Instruments Growth
11.2. PCR Nucleic Acid Extraction
- 11.2.1. Table PCR Nucleic Acid Extraction-by Country
- 11.2.2. Chart-PCR Nucleic Acid Extraction Growth
11.3. PCR Consumables
- 11.3.1. Table PCR Consumables-by Country
- 11.3.2. Chart-PCR Consumables Growth
11.4. PCR Services
- 11.4.1. Table Services-by Country
- 11.4.2. Chart-PCR Services Growth

12. Global PCR Markets-By Place

12.1. PCR Clinical Laboratory
- 12.1.1. Table PCR Clinical Clinical Laboratory-by Country
- 12.1.2. Chart-PCR Clinical Clinical Laboratory Growth
12.2. PCR Point of Care
- 12.2.1. Table PCR Point of Care-by Country
- 12.2.2. Chart-PCR Point of Care Growth
12.3. PCR Commercial
- 12.3.1. Table PCR Commercial-by Country
- 12.3.2. Chart-PCR Commercial Growth
12.4. PCR Pharmaceutical
- 12.4.1. Table PCR Pharmaceutical-by Country
- 12.4.2. Chart-PCR Pharmaceutical Growth
12.5. PCR Other Place
- 12.5.1. Table PCR Other Place-by Country
- 12.5.2. Chart-PCR Other Place Growth

13. Appendices

13.1. Growth of Approved IVD Test Menu
13.2. Growth of Approved Average IVD Test Fee
13.3. The Most Used IVD Assays
13.4. The Highest Grossing Assays
13.5. Laboratory Fees Schedule

Table of Tables

Table 1: Market Players by Type
Table 2: Five Factors Driving Growth
Table 3: Three Factors Limiting Growth
Table 4: Market Size by Country
Table 5: Global Market by Application
Table 6: Global Market by Technology
Table 7: Global Market by Product
Table 8: Global Market by Place
Table 9: PCR Clinical Multiplex by Country
Table 10: PCR Clinical Singleplex by Country
Table 11: PCR Research by Country
Table 12: PCR Other Application by Country
Table 13: qPCR by Country
Table 14: Other Technology by Country
Table 15: PCR Instruments by Country
Table 16: PCR Nucleic Acid Extraction by Country
Table 17: PCR Consumables by Country
Table 18: PCR Services by Country
Table 19: PCR Clinical Clinical Laboratory by Country
Table 20: PCR Point of Care by Country
Table 21: PCR Commercial by Country
Table 22: PCR Pharmaceutical by Country
Table 23: PCR Other Place by Country
Table 24: The Most Common Assays
Table 25: Largest Revenue Assays
Table 26: Clinical Lab Fee Schedule

Table of Figures

Figure 1: The Global Healthcare Market
Figure 2: the Lab Test Pie
Figure 3: The PCR Process
Figure 4: Creation of Sample Droplets for Digital PCR
Figure 5: The Road to Diagnostics
Figure 6: Comparing Syndromic and Targeted Testing
Figure 7: Comparing The New Diagnostics and Traditional Testing
Figure 8: Growth rates of PCR Diagnostic Segments
Figure 9: Base year Global Market Share Chart
Figure 10: PCR Market by Application-Segments Growth
Figure 11: PCR Market by Application-Base vs. final
Figure 12: PCR Market Base year
Figure 13: PCR Market Final Year
Figure 14: Application Share by Year
Figure 15: PCR Market by Technology-Segments Growth
Figure 16: PCR Market by Technology-Base vs. final
Figure 17: PCR Market by Technology Base year
Figure 18: PCR Market by Technology Final Year
Figure 19: Technology Share by Year
Figure 20: PCR Market by Product-Segments Growth
Figure 21: PCR Market by Product-Base vs. final
Figure 22: PCR Market by Product Base year
Figure 23: PCR Market by Product Final Year
Figure 24: Product Share by Year
Figure 25: PCR Market by Place-Segments Growth
Figure 26: PCR Market by Place-Base vs. final
Figure 27: PCR Market by Place Base year
Figure 28: PCR Market by Place Final Year
Figure 29: Place Share by Year
Figure 30: PCR Clinical Multiplex Testing Growth
Figure 31: PCR Clinical Singleplex Testing Growth
Figure 32: PCR Research Growth
Figure 33: PCR Other Application Growth
Figure 34: qPCR Growth
Figure 35: dPCR Growth
Figure 36: Other Technology Growth
Figure 37: PCR Instruments Growth
Figure 38: PCR Nucleic Acid Extraction Growth
Figure 39: PCR Consumables Growth
Figure 40: PCR Services Growth
Figure 41: PCR Clinical Clinical Laboratory Growth
Figure 42: PCR Point of Care Growth
Figure 43: PCR Commercial Growth
Figure 44: PCR Pharmaceutical Growth
Figure 45: PCR Other Place Growth
Figure 46: IVD Test Menu Growth
Figure 47: IVD Test Average Fees-A Ten Year View